194 related articles for article (PubMed ID: 30029060)
21. Amyloid β 3-10 DNA vaccination suggests a potential new treatment for Alzheimer's disease in BALB/c mice.
Xing XN; Zhang WG; Sha S; Li Y; Guo R; Wang C; Cao YP
Chin Med J (Engl); 2011 Sep; 124(17):2636-41. PubMed ID: 22040416
[TBL] [Abstract][Full Text] [Related]
22. A vaccine with Aβ oligomer-specific mimotope attenuates cognitive deficits and brain pathologies in transgenic mice with Alzheimer's disease.
Wang SW; Liu DQ; Zhang LX; Ji M; Zhang YX; Dong QX; Liu SY; Xie XX; Liu RT
Alzheimers Res Ther; 2017 Jun; 9(1):41. PubMed ID: 28592267
[TBL] [Abstract][Full Text] [Related]
23. Amyloid beta-HSP60 peptide conjugate vaccine treats a mouse model of Alzheimer's disease.
Nemirovsky A; Fisher Y; Baron R; Cohen IR; Monsonego A
Vaccine; 2011 May; 29(23):4043-50. PubMed ID: 21473952
[TBL] [Abstract][Full Text] [Related]
24. Active immunization with norovirus P particle-based amyloid-β chimeric protein vaccine induces high titers of anti-Aβ antibodies in mice.
Yang P; Guo Y; Sun Y; Yu B; Zhang H; Wu J; Yu X; Wu H; Kong W
BMC Immunol; 2019 Feb; 20(1):9. PubMed ID: 30755174
[TBL] [Abstract][Full Text] [Related]
25. Immunotherapy for Alzheimer's disease: rational basis in ongoing clinical trials.
Menéndez-González M; Pérez-Piñera P; Martínez-Rivera M; Muñiz AL; Vega JA
Curr Pharm Des; 2011; 17(5):508-20. PubMed ID: 21375481
[TBL] [Abstract][Full Text] [Related]
26. Polymer-Encapsulated Aβ Peptide Fragments as an Oligomeric-Specific Vaccine for Alzheimer's Disease.
Lin X; Bai G; Sutherland K; Costanza F; Breitenkamp K; Sill K; Cai J; Cao C
J Biomed Nanotechnol; 2016 Jul; 12(7):1421-30. PubMed ID: 29336537
[TBL] [Abstract][Full Text] [Related]
27. Alzheimer's disease Advax(CpG)- adjuvanted MultiTEP-based dual and single vaccines induce high-titer antibodies against various forms of tau and Aβ pathological molecules.
Davtyan H; Zagorski K; Rajapaksha H; Hovakimyan A; Davtyan A; Petrushina I; Kazarian K; Cribbs DH; Petrovsky N; Agadjanyan MG; Ghochikyan A
Sci Rep; 2016 Jul; 6():28912. PubMed ID: 27363809
[TBL] [Abstract][Full Text] [Related]
28. DNA immunization with HBsAg-based particles expressing a B cell epitope of amyloid β-peptide attenuates disease progression and prolongs survival in a mouse model of Alzheimer's disease.
Olkhanud PB; Mughal M; Ayukawa K; Malchinkhuu E; Bodogai M; Feldman N; Rothman S; Lee JH; Chigurupati S; Okun E; Nagashima K; Mattson MP; Biragyn A
Vaccine; 2012 Feb; 30(9):1650-8. PubMed ID: 22248819
[TBL] [Abstract][Full Text] [Related]
29. Reduced oligomeric and vascular amyloid-beta following immunization of TgCRND8 mice with an Alzheimer's DNA vaccine.
DaSilva KA; Brown ME; McLaurin J
Vaccine; 2009 Feb; 27(9):1365-76. PubMed ID: 19150380
[TBL] [Abstract][Full Text] [Related]
30. Active Immunotherapy with 12-mer Aβ1-42-like Assembly Vaccine Shows Efficacy in Aged 3×Tg-AD Mice.
Fang H; Zhou G; Li Q; Wang H; Pang X; Xu Q; Yu Y
Curr Mol Med; 2021; 21(1):45-55. PubMed ID: 32338218
[TBL] [Abstract][Full Text] [Related]
31. The generation and characterization of potentially therapeutic Abeta antibodies in mice: differences according to strain and immunization protocol.
Spooner ET; Desai RV; Mori C; Leverone JF; Lemere CA
Vaccine; 2002 Dec; 21(3-4):290-7. PubMed ID: 12450704
[TBL] [Abstract][Full Text] [Related]
32. A comparative evaluation of a novel vaccine in APP/PS1 mouse models of Alzheimer's disease.
Carrera I; Etcheverría I; Fernández-Novoa L; Lombardi VR; Lakshmana MK; Cacabelos R; Vigo C
Biomed Res Int; 2015; 2015():807146. PubMed ID: 25759822
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of a DNA Aβ42 Vaccine in Aged NZW Rabbits: Antibody Kinetics and Immune Profile after Intradermal Immunization with Full-Length DNA Aβ42 Trimer.
Lambracht-Washington D; Fu M; Wight-Carter M; Riegel M; Rosenberg RN
J Alzheimers Dis; 2017; 57(1):97-112. PubMed ID: 28222511
[TBL] [Abstract][Full Text] [Related]
34. Identification of the shortest Aβ-peptide generating highly specific antibodies against the C-terminal end of amyloid-β42.
Axelsen TV; Holm A; Christiansen G; Birkelund S
Vaccine; 2011 Apr; 29(17):3260-9. PubMed ID: 21371581
[TBL] [Abstract][Full Text] [Related]
35. Immunotherapy for Alzheimer's disease: DNA- and protein-based epitope vaccines.
Davtyan H; Petrushina I; Ghochikyan A
Methods Mol Biol; 2014; 1143():259-81. PubMed ID: 24715293
[TBL] [Abstract][Full Text] [Related]
36. Prophylactic immunotherapy of Alzheimer's disease using recombinant amyloid-β B-cell epitope chimeric protein as subunit vaccine.
Yu YZ; Xu Q
Hum Vaccin Immunother; 2016 Nov; 12(11):2801-2804. PubMed ID: 27379885
[TBL] [Abstract][Full Text] [Related]
37. Aβ-HBc virus-like particles immunization without additional adjuvant ameliorates the learning and memory and reduces Aβ deposit in PDAPP mice.
Jin H; Wang W; Zhao S; Yang W; Qian Y; Jia N; Feng G
Vaccine; 2014 Jul; 32(35):4450-4456. PubMed ID: 24962758
[TBL] [Abstract][Full Text] [Related]
38. Effect of rice-expressed amyloid β in the Tg2576 Alzheimer's disease transgenic mouse model.
Nojima J; Maeda A; Aoki S; Suo S; Yanagihara D; Watanabe Y; Yoshida T; Ishiura S
Vaccine; 2011 Aug; 29(37):6252-8. PubMed ID: 21726591
[TBL] [Abstract][Full Text] [Related]
39. Preparation, physiochemical characterization, and oral immunogenicity of Abeta(1-12), Abeta(29-40), and Abeta(1-42) loaded PLG microparticles formulations.
Rajkannan R; Arul V; Malar EJ; Jayakumar R
J Pharm Sci; 2009 Jun; 98(6):2027-39. PubMed ID: 18980172
[TBL] [Abstract][Full Text] [Related]
40. Anti-Aβ antibodies induced by Aβ-HBc virus-like particles prevent Aβ aggregation and protect PC12 cells against toxicity of Aβ1-40.
Feng G; Wang W; Qian Y; Jin H
J Neurosci Methods; 2013 Aug; 218(1):48-54. PubMed ID: 23701997
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
